News
2013
Endocyte Appoints Scot L. Harper, Ph.D., as Vice President of Clinical Operations
–May 7, 2013
Clinical Study Shows Involvement of Activated Macrophages in Osteoarthritis, Identified by Endocyte’s Etarfolatide
–April 25, 2013
Endocyte, Inc. Announces Annual Stockholders’ Meeting
–April 22, 2013
Endocyte Announces First Quarter 2013 Earnings Conference Call
–April 18, 2013
Endocyte Announces Presentations at AACR Annual Meeting 2013
–April 3, 2013
Endocyte to Present at the Future Leaders in the Biotech Industry Conference
–April 1, 2013
Endocyte to Webcast Investor and Analyst Day in New York City
–March 18, 2013
Endocyte to Present at Upcoming Conferences in March
–February 26, 2013
Endocyte Reports Fourth Quarter and Year End 2012 Financial Results and Business Update
–February 25, 2013
Endocyte to Present at Upcoming Conferences
–February 7, 2013
Endocyte Announces Fourth Quarter and Full Year 2012 Earnings Conference Call
–February 6, 2013
Endocyte to Advance Development of EC1069, a PSMA-Targeted Small Molecule Drug Conjugate Therapy for Prostate Cancer
–January 29, 2013
Dr. Lesley Russell Joins the Endocyte Board of Directors
–January 8, 2013
2012
Endocyte to Present at Upcoming Healthcare Conferences
–November 6, 2012
Endocyte Reports Third Quarter 2012 Financial Results and Business Update
–November 1, 2012
Endocyte Announces Third Quarter 2012 Earnings Conference Call
–October 25, 2012
Data Published Identify the Folate Receptor as a Potential Biomarker for Targeted Therapies in a Majority of Lung Cancers
–October 12, 2012
Endocyte Granted Orphan Drug Status for Folic Acid by European Commission
–September 27, 2012
Endocyte, Inc. to Present at Upcoming Health Care and Investor Conferences
–August 28, 2012
Endocyte to Present at the Wedbush PacGrow Life Sciences Management Access Conference
–August 7, 2012
Endocyte Reports Second Quarter 2012 Financial Results and Business Update
–August 2, 2012
Endocyte Secures DOXIL® Supply to Support Ongoing Phase 3 PROCEED Trial in Ovarian Cancer
–August 2, 2012
Endocyte Appoints David Meek to Newly Created Position of Chief Commercial Officer
–July 26, 2012
Marc Kozin Joins the Endocyte Board of Directors
–July 25, 2012
Endocyte Announces Second Quarter 2012 Earnings Conference Call
–July 25, 2012
Peter Meldrum Joins the Endocyte Board of Directors
–July 9, 2012
Endocyte to Present at the JMP Securities 7th Annual Healthcare Conference
–July 3, 2012
Endocyte, Inc. to Present at the Jefferies 2012 Global Healthcare Conference
–May 31, 2012
Endocyte Reports First Quarter 2012 Financial Results and Operations Update
–May 10, 2012
Endocyte Announces First Quarter 2012 Earnings Conference Call
–May 3, 2012
Data on Endocyte’s Vintafolide and Etarfolatide to be presented at the 3rd European Lung Cancer Conference
–April 20, 2012
Merck and Endocyte Enter Exclusive Worldwide Agreement to Develop and Commercialize Phase III Cancer Candidate Vintafolide (EC145)
–April 16, 2012
Endocyte Announces Presentations at AACR Annual Meeting 2012
–March 26, 2012
Endocyte, Inc. Announces Annual Shareholders’ Meeting
–March 23, 2012
Endocyte Receives USAN Approval for Nonproprietary Names of Novel Endocyte Drug Candidates
–March 22, 2012
Endocyte to Submit EU Conditional Marketing Authorization Applications for EC145 and EC20
–March 13, 2012
Endocyte Reports Fourth Quarter and Year End 2011 Financial Results and Operations Update
–March 13, 2012
Endocyte Announces Fourth Quarter and Full Year 2011 Earnings Conference Call
–March 6, 2012
Endocyte to Resume Patient Enrollment in PROCEED Phase 3 Trial in U.S.
–March 5, 2012
Endocyte to Present at the Cowen and Company 32nd Annual Health Care Conference
–February 27, 2012
Endocyte, Inc. to Present at Upcoming Investment Conferences
–February 8, 2012
2011
Endocyte Announces Results of Supplemental Analyses of PRECEDENT Trial
–December 13, 2011
Endocyte Added to NASDAQ Biotechnology Index®
–November 18, 2011
Endocyte Reports Third Quarter 2011 Financial Results and Operations Update
–November 10, 2011
Endocyte Announces Third Quarter 2011 Earnings Conference Call
–November 3, 2011
Endocyte, Inc. to Present at the 18th Annual BioCentury NewsMakers Conference
–October 14, 2011
Endocyte, Inc. to Present at the 17th International Meeting of the European Society of Gynaecological Oncology (ESGO)
–September 8, 2011
Endocyte, Inc. to Present at Upcoming Investor Conferences
–August 31, 2011
Endocyte Reports Second Quarter 2011 Financial Results and Operations Update
–August 11, 2011
Endocyte, Inc. to Present at the Wedbush 2011 Life Sciences Management Access Conference
–August 10, 2011
Endocyte Announces Second Quarter 2011 Earnings Conference Call
–August 4, 2011
Endocyte, Inc. to Present at the Canaccord Genuity 31st Annual Growth Conference
–August 3, 2011
Endocyte Announces Closing of Upsized Public Offering and Exercise of Over-Allotment Option
–August 2, 2011
Endocyte Announces Pricing of Upsized Public Offering
–July 27, 2011
Endocyte Files Registration Statement with SEC for Proposed Public Offering of Common Stock
–July 14, 2011
Endocyte Names Binh Nguyen, M.D., Ph.D. as Vice President of Clinical Affairs
–June 15, 2011
Endocyte, Inc. to Present at the Jefferies 2011 Global Healthcare Conference
–June 1, 2011
Endocyte Reports First Quarter 2011 Financial Results
–May 05, 2011
Endocyte Announces First Quarter 2011 Earnings Conference Call
–April 28, 2011
Endocyte to Present at BioCentury Future Leaders in the Biotech Industry Conference
–April 08, 2011
Endocyte Added to Russell 2000® Index
–April 01, 2011
Endocyte Announces Presentations at AACR 102nd Annual Meeting
–April 01, 2011
Endocyte, Inc. to Present at the Leerink Swann Cancer Roundtable Conference
–March 31, 2011
Endocyte, Inc. Announces Annual Shareholders’ Meeting and Record Date
–March 25, 2011
Endocyte Reports 2010 Financial Results
–March 10, 2011
Endocyte Announces Fourth Quarter Earnings Conference Call
–March 04, 2011
Endocyte announces closing of initial public offering and over-allotment option
–February 09, 2011
Endocyte, Inc. announces pricing of initial public offering
–February 04, 2011
